- Gastroenterology Conference 2020 - All PresentationsOriginal Date: October 16-18, 2020This discounted package includes all of the individual presentations from the conference, which are listed below.15.25 CEUs (general) approved by OBNM
Microbiome Boot CampPresenter: Dr. Andrea McBeth, ND and Dr. Heather ZwickeyOriginal Date: October 16, 2020The human microbiome is an exciting and rapidly evolving space in human health. The importance of its role in gastroenterology cannot be understated. By overviewing the evolution of our understanding of this complex organ like system we can see how it fits within the naturopathic treatment paradigm of wholistic health. I will overview the basic science, clinical research, testing and disease applications.2.25 general CEUs approved by OBNM
Herbs and the MicrobiomePresenter: Dr. Eric YarnellOriginal Date: October 16, 20201.0 general CEUs approved by OBNM
The Broad based Benefits of Bile AcidsPresenter: Dr. Mona Morstein, ND, DHANP, VMIOriginal Date: October 17, 20201.0 general CEUs approved by OBNM
The Limitations of Applying Current Microbiome Science in Clinical PracticePresenter: Dr. Megan Taylor, NDOriginal Date: October 17, 2020Integrative medicine providers, including naturopathic physicians, routinely employ new and emerging science to inform their clinical practice. This practice of early adoption, along with growing interest from the public, has contributed to the explosion in affordable gastrointestinal (GI) microbiome testing marketed to integrative medical practices. These tests are often described as clinically useful tools that can be used to inform treatment of chronic medical conditions, as well as strategies for optimizing general wellness. While these interventions can often be of great benefit to patients, their implementation is not always informed by a nuanced understanding of the limitations of this testing. Commercial microbiome testing in its current form cannot truly nor completely describe an individuals GI microbiome health, except possibly when identifying specific infectious pathogens, nor inform specific interventions (probiotics, prebiotics, etc.) with the accuracy often claimed by the tests themselves, or the physicians employing them. As early adopters, it is our responsibility to not only understand the usefulness of GI microbiome testing, but also its limitations, and ensure that our care is informed by this knowledge. This presentation will review the technology employed in current commercially available microbiome testing and what practitioners should know regarding the limitations of utilizing this technology in clinical practice.NOTE: This talk is not intended to dissuade providers from using GI microbiome tests, but rather encourage thoughtfulness and transparency when utilizing these technologies. I believe that highlighting this discussion in a separate talk (vs combining with a more in-depth review of the technology) will help participants better retain information essential to their PARQ discussions.1.0 general CEUs approved by OBNM
Becoming a Research RockstarPresenter: Dr. Joshua Goldenberg, NDOriginal Date: October 17, 2020Join us for a primer on becoming an integrative medicine critical evaluation rockstar! We go over some key issues that arise commonly in integrative medicine research. Specific topics include unmasking versus blinding, industry sponsorship, spin, straw man comparators, selective outcome reporting, and clinical significance versus statistical significance. Learn how to spot this issues when you read integrative medicine research articles.1.0 general CEUs approved by OBNM
Microbiome Regulated Immunity at a Histological LevelPresenter: Dr. Roz Donovan, NDOriginal Date: October 17, 2020A review of the histological variation of the GI tract with special consideration of the microbiome, immune function and neurotransmitter use and creation. Specifically, the interaction of the goblet cells, glutamate and Akkermansia muciniphila.1.0 general CEUs approved by OBNM
Nutrition and the Human MicrobiotaPresenter: Dr. Cory Szybala, NDOriginal Date: October 17, 2020This will be an overview/update on the impact nutrition has on the human microbiota. I will review specific nutrients and the roles they play as well as a wholistic perspective on what a healthy microbiome diet might look like.1.0 general CEUs approved by OBNM
SIBOPresenter: Dr. Nirala Jacobi, NDOriginal Date: October 17, 2020Small Intestinal Bacterial Overgrowth (SIBO) is a complex condition that is often caused by several factors or triggers. From dysmotility, to digestive deficits, microbiome dysregulation and structural components, finding the underlying cause is key in resolving chronic SIBO cases. Most of us have had opportunities to work with SIBO patients that don’t seem to improve even with well thought out treatment plans. In this presentation, Dr Jacobi explores the contributing factors through which SIBO develops and presents itself by reviewing challenging cases from her practice.1.0 general CEUs approved by OBNM
Oral MicrobiomePresenter: Dr. Steven Sandberg-Lewis, ND, DHANPOriginal Date: October 18, 2020I will use a case of a 62 yo female with intestinal methanogen overgrowth and chronic unresolved dental infections to illustrate the importance of oral abscess as a source of GI microbiome issues. Her endodontist had told her that there was no remaining infection. I had treated her for over a year with some moderate-good responses to treatment before further investigating the oral issues. The investigation was prompted by a relapse of her symptoms despite significant improvement in breath test results. On referring her for a second dental opinion, 5 areas of infection were found along with a stray bone fragment from a previous dental extraction. After just a few injections of ozone into the infected areas and removal of the bone fragment, she had total normalization of her GI and systemic symptoms.I will demonstrate the use of a relatively simple applied kinesiology technique that I use to investigate the presence of significant dental health issues in my GI patients.1.0 general CEUs approved by OBNM
Treating Chronic Derm Problems by Treating the GutPresenter: Dr. Julie Greenberg, NDOriginal Date: October 18, 2020Skin diseases affect approximately 1 in 3 Americans at any given time, and non-dermatologists evaluate over 50% of skin disease that presents in the outpatient setting. As primary care physicians, NDs are on the front line of diagnosing and managing skin conditions. However, dermatology education is sorely lacking in both the ND curriculum as well as in continuing education. While most NDs agree that “all health begins in the gut,” many are not aware of the latest research on changes in the microbiome related to chronic skin disease. NDs therefore often focus treatment on the elimination of foods, which can occasionally be helpful, but more often does not address the root cause of chronic skin disease. While diseases such as rosacea, eczema, acne and psoriasis have complicated pathologies, there is abundant evidence that part of the underlying root cause of these conditions stems from gut microbiome dysfunction. This presentation will present the latest published research on the gut/skin connection in order to provide attendees with the tools they need to formulate effective protocols to treat the toughest derm cases.1.0 general CEUs approved by OBNM
Gut-Liver Axis and Its Impact on Chronic Liver DiseasePresenter: Dr. Vivian Asamoah M.D.Original Date: October 18, 2020The role and function of the liver; clinical diagnosis of underlying liver disease. The importance of the intestinal microbiome (IM) on the gut liver axis and the impact of dysbiosis on chronic liver disease. Pathogenesis and causative factors leading to disease progression: gut dysbiosis, bile acid metabolism chronic inflammation , intestinal permeability, and immune system activation. The impact of these factors on development or progression of chronic liver disease with a particular focus on fatty liver disease and cirrhosis/hepatic encephalopathy. Highlighting the role of IM manipulation in a an attempt to reverse or slow down liver disease through diet, use of studied herbals supplements, prebiotics, probiotics and synbiotics and fecal transplantation. Briefly conclude with practical pearls for the naturopathic clinician to fully understand full scope and benefits of adjunctive therapies available to treat their patient’s with chronic liver disease.1.0 general CEUs approved by OBNM
Shifting Microbial Diversity with the Specific Carbohydrate Diet (SCD)Presenter: Dr. Christine Bowen, ND, GCP (GAPS Certified Practitioner)Original Date: October 18, 2020The Specific Carbohydrate Diet (SCD) was created approximately 100 years ago and has been used to improve IBD symptoms and to induce IBD clinical remission for nearly 100 years. It is just now (in the last 6 years, mostly) starting to gain interest in conventional GI circles, which has lead to more research being conducted. The research has included several studies on how SCD shifts and changes the microbiome. In addition to the research, in my clinical practice I have seen immediate and tangible evidence of these microbial shifts including inhibition of dental caries, skin healing, IBS symptom resolution, mucosal healing (IBD remission), mood and blood sugar regulation and more. Studies have also been conducted on how SCD helps the gut-‐ brain axis in Autism Spectrum Disorders. My presentation will give enough background on SCD to help participants who are unfamiliar have basic knowledge to build on and also is a deep enough dive that is should satisfy participants who are SCD knowledgeable as well. My presentation will include resources for implementing SCD in your practice and deeper dive into the current body of research on how SCD affects the microbiome. I am open to presenting both in pre-‐con as well as at the main conference.1.0 general CEUs approved by OBNM
Meditation and the MicrobiomePresenter: Dr. Emily Wolbers, NDOriginal Date: October 18, 2020The prevalence of anxiety & depression in patients with functional gastrointestinal distress is significantly higher than compared to healthy controls. These numbers shed light on the need for mental health intervention for people suffering from functional digestive distress. This presentation offers a review of current literature on the effect of stress-reduction techniques, specifically mediation, on the microbiome and how to implement beneficial stress-reduction techniques into treatment plans for patients with gastrointestinal distress.1.0 general CEUs approved by OBNM
ProbioticsPresenter: Dr Jason Hawrelak BNat(Hons), PhD, FNHAA, MASN, FACNOriginal Date: October 18, 2020Over the last 20 years, probiotic research has increased exponentially. This has been mirrored by an explosion of probiotic products in the marketplace. With the sheer choice of probiotic supplements and foods available on the market today, it can be challenging for health professionals to sort through each manufacturers’ claims of superiority. In this presentation, Dr Hawrelak will examine the concept of probiotic strain specificity and discuss the shifting paradigm in probiotic prescribing from “re-seeding” to choosing the strain with the desired action for treating specific conditions. He will also share some tips to help clinicians navigate through probiotic marketing claims.1.0 general CEUs approved by OBNM
